NCT00146003View on ClinicalTrials.gov

Efalizumab for Eczema

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

December 31, 2007

Conditions
Dermatitis, Atopic
Interventions
DRUG

Efalizumab treatment

Trial Locations (1)

08903

UMDNJ Psoriasis Center of Excellence, New Brunswick

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

University of Medicine and Dentistry of New Jersey

OTHER

NCT00146003 - Efalizumab for Eczema | Biotech Hunter | Biotech Hunter